There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing technologies allow researchers to either perform an ...
Infiltrating myeloid cells constitute a significant component of the suppressive tumor microenvironment (TME) and possibly contribute to therapeutic failures. An understanding of the immune regulatory ...
The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole ...
A phase 2 basket trial of an ERK1/2 inhibitor (LY3214996) in combination with abemaciclib for patients whose tumors harbor pathogenic alterations in BRAF, RAF1, MAP2K1/2 ERK1/2, and NF1.
Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...
Leica Biosystems, a global leader in anatomic and digital pathology solutions, today unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system ...
Did you enjoy our In Focus, sponsored by Bethyl Laboratories, on multiplex immunofluorescence for cancer research? Now you can access it all in one downloadable feature! Introducing In Focus Wrapped, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback